A NEW HOPE FOR PHYSIQUE CONTROL ?

Scientists are rapidly focused on retatrutide, a promising drug from Eli Lilly, as a possible advance in body management. Different than many previous approaches, retatrutide is a dual -action agonist targeting simultaneously GLP-1 and GIP, substances that impact satiety and blood sugar regulati